Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Molecular Diagnostics : JMD|November 1, 2001
Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screeningA K El-Naggar, L Mao, G Staerkel, et al.
The Journal of Investigative Dermatology|April 1, 1994
Keratinocyte transglutaminase expression varies in squamous cell carcinomasM Duvic, D C Nelson, M Annarella, et al.
Cancer Research|January 1, 1996
Tumor target binding induces phosphorylation of two M(r) 65,000 lymphokine-activated killer proteinsM J Frederick, L V Rodriguez, D A Johnston, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skinJ L Clifford, D G Menter, X Yang, et al.
Archives of Otolaryngology--Head & Neck Surgery|January 1, 1992
Acute-phase proteins in patients with head and neck cancer treated with interleukin 2/interferon alfaG L Clayman, F J Liu, H E Savage, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 1, 1995
Laryngeal preservation for advanced laryngeal and hypopharyngeal cancersG L Clayman, R S Weber, O Guillamondegui, et al.
Cancer|June 4, 1998
The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinomaY T Jin, S Kayser, B L Kemp, et al.
Cancer Research|August 15, 1995
p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerizationS Kanjilal, S S Strom, G L Clayman, et al.
Immunopharmacology|November 1, 1996
Protein tyrosine kinase inhibition blocks granule exocytosis and cytolytic function of lymphokine-activated killer cellsM J Frederick, T K Yu, E G Krohn, et al.
Cancer Research|January 1, 1996
Characterization of the M(r) 65,000 lymphokine-activated killer proteins phosphorylated after tumor target binding: evidence that pp65a and pp65b are phosphorylated forms of L-plastinM J Frederick, L V Rodriguez, D A Johnston, et al.
Pageof 10